Clinical trial
MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating…
NCT00462696 · Institut Bergonié, Other · Completed
Key facts
| NCT number | NCT00462696 |
|---|---|
| Title | MRI in Evaluating Early Response to Chemotherapy in Women With Infiltrating Breast Cancer |
| Official title | Study Evaluating the Contribution of MRI for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Patients With Infiltrative Breast Cancer |
| Acronym | ISNA-Sein |
| Lead sponsor | Institut Bergonié, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Neoadjuvant chemotherapy |
| Enrollment | 16 |
| Start date | Feb 1, 2006 |
| Primary completion | Dec 31, 2008 |
| Completion | Dec 31, 2008 |
| First posted | Apr 19, 2007 |
| Last update posted | Oct 6, 2025 |
| Countries | France |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: